Jennifer Heideman

A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors

Christos E. Kyriakopoulos, Amy Braden, Jill Kolesar et al. · Investigational New Drugs · 2016 · 23 citations · Full text

Surgical Oncology, Medicine, Pathology +7

A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of¹³¹I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies

Sam Joseph Lubner, Jacqueline Ann Mullvain, Scott B. Perlman et al. · Cancer Investigation · 2015 · 22 citations

Dose-escalation Study, Oncologic Imaging, Medicine +14

A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer

Noelle K. LoConte, James P. Thomas, Dona Alberti et al. · Cancer Chemotherapy and Pharmacology · 2008 · 22 citations

Advanced Cancer, Medicine, Pharmacology +7

Potential cytochrome P-450 drug–drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials

Kari B. Wisinski, Colby A. Cantu, Jens C. Eickhoff et al. · American Journal of Health-System Pharmacy · 2015 · 15 citations · Full text

Phase I study to determine tolerability and pharmacokinetics (PK) of SB-743921, a novel kinesin spindle protein (KSP) inhibitor

Kyle D. Holen, Chandra P. Belani, G. Wilding et al. · Journal of Clinical Oncology · 2006 · 15 citations

Pathology, Pharmacotherapy, Tumor Biology +16